TSTL
VERY GOODTristel Delivers Another Year of Strong Growth
The healthcare company reports strong financial results, with double-digit revenue and profit growth, and a robust balance sheet.
Tristel
379.94GBX
-0.41%
Market Cap
197.67M
Volume
19.49k
24% of avg
P/E Ratio
0.21
EPS (TTM)
17.9
Beta
0.22
Day Range
376.50p - 380.20p
52 Week Range
260.00p379.94p510.00p
379.94p
Upcoming Events
TSTL
NEUTRALTristel Confirms Upcoming Investor Presentations
The healthcare company is hosting investor presentations next week, providing an opportunity for shareholders and analysts to engage with the management team.
TSTL
NEUTRALTristel Appoints New Chief Financial Officer
The healthcare company has appointed a new Chief Financial Officer with extensive experience in the medical devices and technology sectors.
TSTL
NEUTRALTristel Plc Announces Holding Change
The healthcare company has announced a change in shareholding, with Liontrust Investment Partners LLP increasing its stake to 9.95%.
TSTL
NEUTRALTristel Exhibits at APIC25 Conference and Launches Tristel OPH in the U.S.
The healthcare company showcased its infection prevention products at a major U.S. conference and announced the launch of a new disinfectant for ophthalmic instruments.
TSTL
NEUTRALTristel Announces Investor Presentations and Trading Update
The healthcare company is hosting investor presentations and providing a trading update, but no financial details are disclosed.
TSTL
NEUTRALTristel Plc Announces Holding(s) in Company
The healthcare company has received a notification of a change in major shareholding.
TSTL
NEUTRALTristel to Present at Mello2025 Investor Event
The healthcare company will be presenting and exhibiting at the upcoming Mello2025 investor event.
TSTL
NEUTRALTristel Announces Exercise of Share Options
The healthcare company has issued new shares following the exercise of employee share options, but details on the raise price are not provided.
TSTL
NEUTRALTristel Announces CFO Succession Planning
The healthcare company announces its Chief Financial Officer will retire, with a process underway to appoint a successor.